Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 8 (August)

1. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development.
   J Natl Cancer Inst, 98(15): 1060-7. [Abstract] [Full-text]
2. Validity of melanoma diagnosis in a community-based screening program.
   Am J Epidemiol, 164(4): 385-90. [Abstract] [Full-text]
3. Intraparotid sentinel lymph node biopsy for head and neck melanoma.
   Laryngoscope, 116(8): 1461-4. [Abstract] [Full-text]
4. Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.
   Am J Clin Oncol, 29(4): 352-60. [Abstract] [Full-text]
5. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
   J Clin Oncol, 24(23): 3771-9. [Abstract] [Full-text]
6. B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.
   Oncogene, 25(35): 4848-56. [Abstract] [Full-text]
7. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.
   Oncogene, 25(35): 4923-36. [Abstract] [Full-text]
8. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
   Br J Cancer, 95(4): 496-505. [Abstract] [Full-text]
9. Pathways to the development of melanoma: a complex issue.
   J Invest Dermatol, 126(9): 1932-3. [Abstract] [Full-text]
10. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
    J Invest Dermatol, 126(9): 2106-10. [Abstract] [Full-text]
11. Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling.
    Nucleic Acids Res, 34(13): 3819-32. [Abstract] [Full-text]
12. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
    Int J Cancer, 119(6): 1312-5. [Abstract] [Full-text]
13. In vivo imaging of tumor growth after electrochemotherapy with cisplatin.
    Biochem Biophys Res Commun, 348(3): 997-1002. [Abstract] [Full-text]
14. ARLTS1 variants and melanoma risk.
    Int J Cancer, 119(7): 1736-7. [Abstract] [Full-text]
15. Clinical and cytogenetic analyses in uveal melanoma.
    Invest Ophthalmol Vis Sci, 47(9): 3703-7. [Abstract] [Full-text]
16. Increased migration and metastatic potential of tumor cells expressing aquaporin water channels.
    FASEB J, 20(11): 1892-4. [Abstract] [Full-text]
17. Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
    Br J Cancer, 95(5): 581-6. [Abstract] [Full-text]
18. Rapid screening of 4000 individuals for germ-line variations in the BRAF gene.
    Clin Chem, 52(9): 1675-8. [Abstract] [Full-text]
19. Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo.
    Int J Cancer, 119(8): 1869-77. [Abstract] [Full-text]
20. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    J Clin Oncol, 24(25): 4196-201. [Abstract] [Full-text]
21. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma.
    J Surg Oncol, 94(4): 287-92. [Abstract] [Full-text]
22. The role of surgery in treatment of stage IV melanoma.
    J Surg Oncol, 94(4): 344-51. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.